Viewing nowCombinationCrestive Tablet 10/5mg
Rosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharm Co., Ltd.

MFDS item code 201601213 · Approved 2016.02.29 · Insurance code 649103480
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps reduce total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol in the blood of patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol to reduce the risk of cardiovascular disease. It is used in conjunction with dietary therapy and is administered as an adjunct when dietary therapy alone is insufficient. It is important to identify and treat secondary causes of hyperlipidemia before medication administration, and lipid levels are monitored regularly. This is effective in reducing the risk of atherosclerotic vascular disease and improving health. Therefore, this medication is used in the treatment of dyslipidemia.
Administer this medication once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can rarely cause rhabdomyolysis, which may lead to serious kidney dysfunction due to muscle tissue damage, so patients showing severe myopathy symptoms or at high risk for rhabdomyolysis should temporarily discontinue or stop this medication. This medication should not be used in patients with certain diseases or conditions. For example, it should not be given to patients with allergies to any of the components of this medication, those with severely impaired liver function, patients with muscle diseases, those taking specific immunosuppressants, those with severe kidney dysfunction, pregnant women, or women who may become pregnant, and nursing mothers. Patients at high risk for muscle diseases or rhabdomyolysis, alcoholics, those with a history of liver disease or moderate to severe liver dysfunction, elderly patients, or those taking particular medications should use this medication with caution, and regular monitoring may be required as directed by a physician. While taking this medication, if symptoms such as muscle pain, muscle cramps, muscle weakness, fatigue, or fever occur, the patient should immediately inform a doctor and undergo an examination, and discontinuation of the medication may be necessary in cases of severe muscle damage. As this medication can affect liver function, liver function tests should be performed before and during treatment, and if liver enzyme levels significantly exceed the normal range, the use of the medication should be discontinued or the dosage adjusted. Pregnant or nursing women should not use this medication as it may harm the fetus or newborn, and women of childbearing age should use appropriate contraception. This medication is not recommended for children as safety and efficacy have not been sufficiently established. Elderly patients should use this medication with caution as the risk of myopathy may increase. There may be interactions with other medications, so patients, especially those taking specific antibiotics, antifungals, immunosuppressants, anticoagulants, fibrate class drugs, etc., should consult with their doctor or pharmacist. In case of overdose, there is no specific antidote; therefore, treatment should be symptomatic and appropriate supportive care should be administered, monitoring liver function and muscle enzyme levels.
Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, elevated blood bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial edema, strange feeling, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, somnolence, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes mellitus, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorder, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid ptosis, diabetic retinopathy, ear discomfort, kidney dysfunction, benign esophageal neoplasm, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis syndrome, weakness, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscular weakness, ocular myasthenia, increased CK, chest pain, chest discomfort, systemic edema, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, low back pain, hypoglycemia, anemia, splenomegaly, hyperhidrosis, conjunctival injection, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased blood urea, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture and should be stored in a tightly sealed container. It is essential to maintain room temperature between 1 degree and 30 degrees Celsius. Proper storage helps to preserve the medication's effectiveness for a longer period.
White to almost white round film-coated tablet
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharm Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.